6-K 1 sn201208016k.htm DIRECTOR DECLARATION sn201208016k.htm
 
 
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549
 
 
Report of Foreign Private Issuer
 
 
Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of

1934
 
 
August 01, 2012 
 
Commission File Number 001-14978


SMITH & NEPHEW plc
(Registrant's name)


15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)

 
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]

 
Form 20-F X                Form 40-F
    ---                               ---

[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]


Yes                        No X
---                         ---

 
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]

 
Yes                      No X
---                         ---

[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]

 
Yes                  No X
---                   ---

 
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.





 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Smith & Nephew Plc
(Registrant)
 
 
Date: August 01, 2012
 
 
By: /s/ Susan Swabey
-----------------
Susan Swabey
Company Secretary
 
 
 



01 August 2012
 
Smith & Nephew plc
 
DIRECTOR DECLARATION
 
In accordance with Listing Rule 9.6.14 R the Company announces that Richard De Schutter, Non-executive Director, was appointed Chairman and Independent Director of Durata Therapeutics Inc on 30 April 2012. Durata Therapeutics Inc was subsequently listed on the NASDAQ on 17 July 2012.
 
Contact:
 
Gemma Parsons
Deputy Company Secretary
Smith & Nephew plc
 
Tel:  +44 (0)20 7401 7646